The relationship between income, health insurance, and employment status as prognostic indicators of bladder cancer: A survival analysis
https://doi.org/10.4081/aiua.2024.12305
Accepted: February 10, 2024
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Background: Bladder cancer (BC) is one of the health problems. Socioeconomic status (SES) may correlate with patient treatment, possibly impacting patient prognosis. This study aimed to determine the relationship between income, health insurance, and employment status as prognostic indicators of BC.
Methods: A retrospective observational study for patients diagnosed with BC in a hospital during the 5-year period between January 2019 and December 2023. Kaplan-Meier test analysis was used to generate overall survival curves stratified by income, employment status, and health insurance. Multivariate Cox proportional-hazards regression was used to identify factors associated with worse overall survival.
Results: The results of the analysis on 219 patients showed no difference in patient survival based on income (p>0.05), while employment status and health insurance showed significant difference in patient survival (p<0.05). Moreover, there were 99 (45.2%) patients died, with the average patient being 58 years old and dominant in male patients.
Conclusions: Prevention of poor outcomes in patients needs to pay attention to certain characteristics, particularly for the loweconomic patients without appropriate national health insurance coverage.
Kaseb H, NR. A. Bladder Cancer. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2023.
IARC. Bladder cancer. 2023; Available from: https://www.iarc.who.int/cancer-type/bladder-cancer/
Saginala K, Barsouk A, Aluru JS, et al. Epidemiology of Bladder Cancer. Med Sci. 2020;8:15. DOI: https://doi.org/10.3390/medsci8010015
Cumberbatch MGK, Noon AP. EAU on behalf of the Young Academic Urologists- Urothelial Cancer Working party. Epidemiology, aetiology and screening of bladder cancer. Transl Androl Urol 2019;8:5-11. DOI: https://doi.org/10.21037/tau.2018.09.11
Ripoll J, Ramos M, Montaño J, et al. Cancer-specific survival by stage of bladder cancer and factors collected by Mallorca Cancer Registry associated to survival. BMC Cancer 2021;21:676. DOI: https://doi.org/10.1186/s12885-021-08418-y
Rezaianzadeh A, Mohammadbeigi A, Mobaleghi J, Mohammadsalehi N. Survival analysis of patients with bladder cancer, life table approach. J Midlife Health. 2012;3:88-92. DOI: https://doi.org/10.4103/0976-7800.104468
Bethesda (MD): National Cancer Institute (US). PDQ Cancer Information Summaries: Bladder Cancer Treatment: Patient Version. 2023; Available from: https://www.ncbi.nlm.nih.gov/books/NBK66044/
Afshar N, English DR, Blakely T, et al. Differences in cancer survival by area-level socio-economic disadvantage: A population-based study using cancer registry data. PLoS One 2020;15:e0228551. DOI: https://doi.org/10.1371/journal.pone.0228551
Michaeli JC, Boch T, Albers S, et al. Socio-economic burden of disease: Survivorship costs for bladder cancer. J Cancer Policy 2022;32:100326. DOI: https://doi.org/10.1016/j.jcpo.2022.100326
Russell B, Häggström C, Holmberg L, et al. Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators. BJUI Compass. 2021;2:140-58. DOI: https://doi.org/10.1002/bco2.65
Taylor A, Gallegos JM, Verplancke K, et al. Socioeconomic factors associated with stages of bladder cancer at diagnosis: Analysis of the National Cancer Database. J Clin Oncol 2022;40:e16531-e16531. DOI: https://doi.org/10.1200/JCO.2022.40.16_suppl.e16531
Nazemi A, Ghodoussipour S, Pearce S, et al. Socioeconomic and insurance status are independent prognostic indicators of higher disease stage and worse prognosis in bladder cancer. Urol Oncol Semin Orig Investig 2019;37:784-90. DOI: https://doi.org/10.1016/j.urolonc.2019.04.021
Fang W, Yang ZY, Chen TY, et al. Ethnicity and survival in bladder cancer: a population-based study based on the SEER database. J Transl Med 2020;18:145. DOI: https://doi.org/10.1186/s12967-020-02308-w
Andreassen BK, Grimsrud TK, Haug ES. Bladder cancer survival: Women better off in the long run. Eur J Cancer 2018; 95:52-8. DOI: https://doi.org/10.1016/j.ejca.2018.03.001
Sukartini T, Arifin H, Kurniawati Y, et al. Factors Associated with National Health Insurance Coverage in Indonesia. F1000 Res. 2021;10:563. DOI: https://doi.org/10.12688/f1000research.53672.1
Amiri M, Heshmatollah S, Esmaeilnasab N, et al. Survival rate of patients with bladder cancer and its related factors in Kurdistan Province (2013-2018): a population-based study. BMC Urol 2020;20:1-9. DOI: https://doi.org/10.1186/s12894-020-00769-1
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
